Skip to main content

Table 1 Comparison of patient sociodemographic and clinical characteristics by age group

From: Assessment of physical function, quality of life, and medication adherence in elderly patients with rheumatic diseases

   

18–64 years

(group1, n = 85)*

n (%)

≥ 65 years

(group 2, n = 89)*

n (%)

Total*

n (%)

P

Gender

      

 Female

  

41 (48.2)

58 (65.2)

99 (56.9)

0.024

 Male

  

44 (51.8)

31 (34.8)

75 (43.1)

Occupational status

      

 Housewife

  

30 (35.3)

51 (57.3)

81 (46.6)

< 0.001

 Employed

  

41 (48.2)

14 (15.7)

55 (31.6)

 Unemployed

  

14 (16.5)

24 (27)

38 (21.8)

Maritalstatus

      

 Single/never married

  

18 (21.2)

0 (0)

18 (10.3)

< 0.001

 Married

  

63 (74.1)

64 (71.9)

127 (73)

Separated/divorced/widowed

  

4 (4.7)

25 (28.1)

29 (16.7)

Place of residence

      

 Urban

  

75 (88.2)

74 (83.1)

149 (85.6)

0.459

 Rural

  

10 (11.8)

15 (16.9)

25 (14.4)

Rheumatic diseases

      

 Ankylosing spondylitis

  

39 (45.9)

13 (14.6)

52 (29.9)

< 0.001

 Rheumatoid arthritis

  

31 (36.5)

62 (69.7)

93 (53.4)

 Gout

  

4 (4.7)

8 (9)

12 (6.9)

 Polymyalgia rheumatica

  

2 (2.4)

2 (2.2)

4 (2.3)

 Psoriatic arthritis

  

9 (10.6)

4 (4.5)

13 (7.5)

First application complaints before diagnosis

      

 Knee pain

  

8 (9.4)

14 (15.7)

22 (12.6)

< 0.001

 Arthralgia

  

12 (14.1)

12 (13.5)

24 (13.8)

 Hip pain

  

19 (22.4)

0 (0)

19 (10.9)

 Lower back and hip pain

  

17 (20)

7 (7.9)

24 (13.8)

 Hand polyarthritis

  

23 (27.1)

44 (49.4)

67 (38.5)

 Metatarsophalangeal arthritis

  

3 (3.5)

11 (12.4)

14 (8)

 Rash/dactylitis

  

3 (3.5)

1 (1.1)

4 (2.3)

Having undergone orthopedic surgery for rheumatic diseases

      

 Yes

  

2 (2.4)

16 (18)

18 (10.3)

0.002

 No

  

83 (97.6)

73 (82)

156 (89.7)

The surgical area that required replacement surgery

      

 Knee

  

1 (1.2)

7 (7.9)

8 (4.6)

0.005

 Hip

  

0 (0)

7 (7.9)

7 (4)

 Femur

  

0 (0)

2 (2.2)

2 (1.1)

 Ankle

  

1 (1.2)

0 (0)

1 (0.6)

 No

  

83 (97.6)

73 (82)

156 (89.7)

Comorbid diseases

      

 Yes

  

23 (27.1)

80 (89.9)

103 (59.2)

< 0.001

 No

  

62 (72.9)

9 (10.1)

71 (40.8)

  1. P ≤ 0.05, *n (%)
  2. P ≤ 0.05 is considered significant